Presentation Information
[P3-15]Multi-laboratory evaluation study of LC-MS based bioanalytical method for BT1718 in plasma
*Rika Ishikawa1, Koichi Shiga2, Kazuki Yamamoto3, Koichiro Hotta4, Masayoshi Mizuochi5, Mitsuhiko Kawabata6, Takuma Shigeyama7, Hitomi Shimoda8, Hisashi Fujita9, Norihiko Iwazaki10, Ryo Yamato11, Takashi Misawa1, Yosuke Demizu1, Yoshiro Saito1, Ruri Kikura-Hanajiri1, Kosuke Saito1 (1. National Institute of Health Sciences, 2. Axcelead Drug Discovery Partners, Inc., 3. Ajinomoto. Co., Inc., 4. Eisai Co., Ltd., 5. CMIC Pharma Science Co., Ltd., 6. Shin Nippon Biomedical Laboratories, Ltd., 7. Sumika Chemical Analysis Service, Ltd., 8. Daiichi Sankyo Co., Ltd., 9. Takeda Pharmaceutical Company Limited, 10. Mitsubishi Tanabe Pharma Corporation, 11. Mediford Corporation)
Keywords:
Peptide-drug conjugate (PDC),Liquid chromatography-mass spectrometry,BT1718
Password required to view
Log in
or
Comment
To browse or post comments, you must log in.Log in